Skip to content

Jakks Pacific JAKK Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.5M-27.0%
CarGurus, Inc. logo
CarGurus, Inc.CARG
$980.25K
ESN
Essent GroupESNT
$79K-61.8%
Vertex, Inc. logo
Vertex, Inc.VERX
$1.13M-8.4%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$844.25K
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$330.75K-25.0%

Other financials

Income statement

See full
Revenue$106.7M-5.8%
Gross profit$35.6M-8.7%
Operating income-$5.6M-48.4%
Net income-$4.3M-79.7%
EPS (diluted)-$0.37-76.2%

Balance sheet

See full
Cash & equivalents$64.0M+7.7%
Total debt$50.0M-12.1%
Total equity$242.0M+3.2%
Total assets$400.4M-1.3%

Cash flow

See full
Operating cash flow$21.8M+1,382%
CapEx$5.6M+170%
Free cash flow$16.2M+530%

Valuation

See full
Market cap$266.43M+17.5%
Enterprise value$252.47M+5.3%
P/E24.4×-18.1×
P/S0.5×-0.1×

Profitability

See full
Gross margin31.6%+0.8pp
Operating margin9.3%+2.8pp
Net margin12.2%+6.3pp
FCF margin3.1%

Returns & leverage

See full
Return on equity57.5%-3.4pp
Debt / equity0.2×0.0×
Current ratio0.0×

Where this comes from

Reported directly by Jakks Pacific in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.

The official record: Jakks Pacific’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jakks Pacific's effective income tax rate reconciliation, tax credit, research, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jakks Pacific's effective income tax rate reconciliation, tax credit, research, amount?
Jakks Pacific (JAKK) reported effective income tax rate reconciliation, tax credit, research, amount of $19.75K in Q4 2025.
What does effective income tax rate reconciliation, tax credit, research, amount mean?
Represents the dollar amount of tax credits claimed for qualified research and development expenditures. It highlights the company's commitment to innovation and the extent to which R&D investment is subsidized through tax policy.